SPRY241220C22500
- 0.05
- 0.000.00%
ARS Pharmaceuticals Newsroom
Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.09 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 15, $ARS Pharmaceuticals(SPRY.US)$ Officer Chakma Justin intends to sell 236.38K shares of its common stock on Nov 15, with a total market value of approximately $4.09
Express News | Neurelis Enters $208 Million Agreement to Monetize Intravail Royalties
ARS Pharmaceuticals Insider Sold Shares Worth $10,143,706, According to a Recent SEC Filing
Express News | ARS Pharmaceuticals Inc : Leerink Partners Raises Target Price to $26 From $25
ARS Pharmaceuticals' Strong Q3 2024 Highlights
ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$10.14 Million in Common Stock
ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript Summary
Express News | ARS Pharmaceuticals Shares Are Higher Lower After the Company Reported Better-than-expected Q3 Sales Results
ARS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
ARS Pharmaceuticals' Q3 Net Loss Widens
ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Misses Revenue Estimates
Express News | ARS Pharmaceuticals Q3 2024 GAAP EPS $(0.20) Misses $(0.14) Estimate, Sales $2.068M Beat $565.000K Estimate. Cash and Equivalents Of $349.6M
Earnings Flash (SPRY) ARS PHARMACEUTICALS Reports Q3 Revenue $2.1M
Express News | ARS Pharmaceuticals: Cash, Cash Equivalents and Short-Term Investments Were $204.6 Mln as of September 30, 2024
Express News | ARS Pharmaceuticals: Pdufa Target Date Set for March 6, 2025
Express News | ARS Pharmaceuticals Q3 Revenue USD 568 Thousand Vs. IBES Estimate USD 575 Thousand
Express News | ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
Express News | ARS Pharmaceuticals Q3 Operating Expenses USD 23.816 Million
Express News | ARS Pharmaceuticals Q3 Operating Income USD -21.748 Million